Glenmark launches COVID-19 drug after DCGI nod
Posted by
www.biotecnika.org
The company hopes that the availability of an effective treatment such
as FabiFlu will considerably help assuage this pressure, and offer
patients in India a much needed and timely therapy option, he added.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-launches-covid-19-drug-after-dcgi-nod/articleshow/76479268.cms
Subscribe to:
Post Comments (Atom)
Post a Comment